Series B - Barosense

Series B - Barosense

Investment Firm

Overview

BaroSense develops minimally-invasive therapeutic weight loss procedures, devices and surgical treatments for the obese.

Announced Date

Dec 22, 2004

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorRWI Group
Participant InvestorUniversity Growth Fund
Participant InvestorDelphi Ventures
Participant InvestorFrazier Healthcare Partners

Round Details and Background

Barosense raised $6200000 on 2004-12-22 in Series B

BaroSense develops minimally-invasive therapeutic weight loss procedures, devices and surgical treatments for the obese.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 05, 2007
Series C - Barosense
6-11.2M
Dec 22, 2004
Series B - Barosense
4-6.2M
Jul 22, 2002
Series A - Barosense
2-6.2M
Aug 24, 2009
Series D - Barosense
8-27.0M

Recent Activity

There is no recent news or activity for this profile.